Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto-Immune Diseases
2019-10-30 19:00
EC Approves Astellas' XOSPATA(TM) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe's LeukoStrat(R) CDx FLT3 Mutation Assay
2019-10-30 18:00
Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit
2019-10-29 13:17
European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma
2019-10-29 02:00
Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis
2019-10-28 20:30
HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)
2019-10-28 08:38
WuXi STA's Jinshan Facility Passes EMA Inspection
2019-10-28 08:00
HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH)
2019-10-26 19:00
Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences
2019-10-26 18:01
Fountain Medical Development Limited Announces $62 mm Series D Round Financing, Further Strengthening its Global Services Capabilities
2019-10-25 14:06
/C O R R E C T I O N -- Menarini I.F.R./
2019-10-25 06:28
World Federation of Neurology Reveals New Frontiers in Epilepsy Treatment for Children, Pregnant Women and, New Links Between ADHD and Epilepsy at 24th Annual World Congress of Neurology, Dubai, Oct 27 - 31
2019-10-24 21:00
World first clinical trial commenced in alcohol use disorder
2019-10-24 12:01
Mundipharma Thailand Recognised as "Best Companies to Work for in Asia" Award
2019-10-23 13:32
Chugai Renews License to EpiVax's ISPRI In Silico Toolkit for Immunogenicity Assessment
2019-10-23 04:10
BioGX Receives CE-IVD Mark For Enhanced Flu Assay
2019-10-22 20:07
Zuellig Pharma enters into strategic partnership with Eli Lilly and Company in Malaysia and Thailand
2019-10-22 17:10
GN Corporation and Edogawa Evolutionary Laboratory of Science Cosponsor International Academic Conference, NCRM NICHE 2019, on October 15, 2019
2019-10-21 14:00
Mundipharma Wins "Best Companies to Work for in Asia" Award in Singapore for Third Time Running
2019-10-21 11:49
Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma
2019-10-21 08:00
1
303
304
305
306
307
401